A01K 2217/072
Maintaining or altering function, i.e. knock in
Official title: maintaining or altering function, i.e. knock in
A01K2217/072 (Maintaining or altering function, i.e. knock in) appears on 824 US grants and 1,748 published applications in this corpus.
Search patents in A01K- Granted patents
- 824
- Published applications
- 1,748
- Assignees
- 542
- Inventors
- 2,353
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 14 | 0 |
| 2001 | 6 | 0 |
| 2002 | 7 | 68 |
| 2003 | 9 | 77 |
| 2004 | 13 | 30 |
| 2005 | 10 | 39 |
| 2006 | 13 | 72 |
| 2007 | 8 | 26 |
| 2008 | 12 | 20 |
| 2009 | 15 | 26 |
| 2010 | 12 | 21 |
| 2011 | 12 | 29 |
| 2012 | 11 | 35 |
| 2013 | 14 | 57 |
| 2014 | 24 | 60 |
| 2015 | 37 | 93 |
| 2016 | 42 | 86 |
| 2017 | 51 | 105 |
| 2018 | 58 | 80 |
| 2019 | 56 | 117 |
| 2020 | 62 | 118 |
| 2021 | 64 | 107 |
| 2022 | 50 | 101 |
| 2023 | 58 | 98 |
| 2024 | 53 | 121 |
| 2025 | 54 | 95 |
| 2026 | 40 | 67 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Cells, vertebrates, populations and methods4 Aug 2026US 12,696,885 B2Kymab Limited
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Method for gender determination of chicken embryos24 Sep 2026US 2026/0283125 A1Eggxyt Ltd.
- Antibody against hepatitis b virus, preparation thereof and use thereof27 Aug 2026US 2026/0250361 A1Huahui Health Ltd.
- Chinese hamster artificial chromosome vector or fragment thereof and mammalian-derived cell comprising the same27 Aug 2026US 2026/0250706 A1Trans Chromosomics, Inc.
Most cited
By later US patents
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998